Healthcare -
Biotechnology - NASDAQ - US
$ 74.17
1.57 %
$ 9.55 B
Market Cap
-19.52
P/E
PCVX - OPERATING EXPENSES
Operating Expenses PCVX - Vaxcyte, Inc.
468 M
LAST VALUE
114.12%
2 YEAR CAGR
67.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR